Bio-Rad Laboratories, Inc. (NYSE:BIO) Given Consensus Recommendation of “Reduce” by Analysts
Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Free Report) has been given a consensus rating of “Reduce” by the five research firms that are currently covering the company, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell recommendation, two have assigned a hold recommendation and one has given a buy recommendation […]
19 Jul 08:29 · The Markets Daily